Precision Peptide Therapy

Targeted peptides for mood, cognition, and function

Peptides are endogenous signaling molecules with tissue-specific, receptor-specific mechanisms. At Welmivia, they extend psychiatric treatment into domains that standard medications don't reach — social bonding, sexual function, sleep architecture, neuroinflammation, and tissue repair. Every prescription requires a documented psychiatric indication.

Schedule a Fit Call
  • Category 1 — Neuromodulatory & Anxiolytic
  • Category 2 — Sexual Function & Intimacy
  • Category 3 — GH Secretagogues
  • Category 4 — Amino Acid Therapeutics
  • Category 5 — Dermatologic & Tissue Repair

Rx Required

Psychiatric diagnosis prerequisite

503A Pharmacy

Compounded via Empower & Preston's

Membership

Required for ongoing monitored therapy

Not Cosmetic

Every agent is clinically justified

Clinical Philosophy

Peptides as psychiatric precision instruments

Peptide therapy at Welmivia is a precision psychiatric intervention — not a longevity spa service, not a biohacking offering, and not cosmetic medicine.

Peptides are endogenous molecules or analogs thereof — generally well-tolerated, with tissue-specific and receptor-specific mechanisms that allow targeted intervention without the broad systemic burden of many conventional pharmaceuticals.

This framework is for patients whose presentations involve domains — social disconnection, sexual dysfunction, cognitive slowing, somatic burden — that precision tools can meaningfully address.

Every peptide prescription at Welmivia requires: (1) a documented qualifying psychiatric diagnosis, (2) a clinical narrative linking the peptide's mechanism to the psychiatric presentation, and (3) an active Core or Signature membership for ongoing monitored therapy.

The Welmivia Formulary

Agents by therapeutic category

Neuromodulatory

Oxytocin

Intranasal

Amygdala fear modulation · Social bonding · Anxiety · PTSD

Oxytocin reduces amygdala reactivity to social threat, enhances trust and approach behavior, and reduces stress-axis reactivity. Central concentrations achieved via olfactory and trigeminal nerve pathways with intranasal delivery.

  • Primary indication: Social anxiety disorder (F40.10)
  • PTSD hyperarousal and trust impairment (F43.10)
  • MDD with social withdrawal and anhedonia
  • Sexual dysfunction — intimacy facilitation
  • Avoid in active psychosis

BPC-157

SQ or Topical

Gut-brain axis · Neuroinflammation · Dopaminergic support

BPC-157 modulates the gut-brain axis, restores dopamine receptor function, reduces neuroinflammation, and promotes vascular healing. Topical formulation addresses excoriation disorder scarring and body image distress.

  • Treatment-resistant or high-inflammation MDD
  • Somatic symptom disorder with GI overlay
  • PTSD with somatic pain burden
  • Topical: excoriation disorder, self-harm scarring
  • ⚠ Verify 503A availability — regulatory status subject to change

Sexual Function

PT-141 (Bremelanotide)

Intranasal / SQ

Central melanocortin receptor · Desire · SSRI-induced dysfunction

PT-141 acts centrally in the hypothalamus to increase sexual desire and arousal. Its mechanism is entirely distinct from PDE5 inhibitors — operating upstream of the vascular pathway. The agent of choice for SSRI-induced loss of desire.

  • SSRI/SNRI-induced sexual dysfunction — primary indication
  • HSDD — FDA approved (SQ)
  • Psychogenic erectile dysfunction
  • Can be co-formulated with oxytocin
  • Transient BP elevation — do not combine with nitrates

Sildenafil (Compounded)

Oral / Sublingual

PDE5 inhibitor · Vascular mechanism · SSRI adjunct

Compounded sublingual sildenafil for SSRI-induced erectile dysfunction with a vascular-peripheral mechanism, and for situational performance anxiety where the peripheral mechanism is intact but anxiety disrupts initiation.

  • SSRI-induced ED — peripheral vascular mechanism
  • Performance anxiety with intact vascular response
  • Sublingual: 15–30 min onset vs 30–60 min oral
  • CYP3A4 interaction with many psychiatric medications — start low
  • Absolute contraindication: nitrates in any form

GH Secretagogues

CJC-1295 / Ipamorelin

SQ — Bedtime Dosing

GH secretagogue · Sleep architecture · Executive function · Neuroplasticity

CJC-1295 (GHRH analog) combined with Ipamorelin (selective GH secretagogue) produces synergistic GH release that restores the nocturnal GH pulse disrupted by chronically poor sleep — a near-universal feature of mood and anxiety disorders. Benefits include normalized sleep architecture, improved executive function, reduced fatigue, and lean mass preservation in patients on metabolically burdensome psychiatric medications.

Psychiatric Indications

  • ADHD with sleep and executive function impairment
  • MDD with fatigue and cognitive slowing
  • Bipolar disorder — sleep normalization
  • Antipsychotic metabolic burden

Dosing Notes

  • Bedtime dosing critical — aligns with physiologic GH pulse
  • IGF-1 monitoring at baseline and 6–8 weeks
  • Cognitive and sleep benefits at 3–4 weeks
  • Full effect by 8–12 weeks

Contraindications

  • Active malignancy
  • Hormone-sensitive cancer history
  • Active pituitary pathology
  • Monitor fasting glucose in diabetic patients

Tissue & Skin Repair

GHK-Cu

Topical

Copper peptide · Collagen synthesis · Follicular repair · Anti-inflammatory

GHK-Cu promotes collagen and elastin synthesis, wound healing, and anti-inflammatory scalp and skin effects. In psychiatric practice, it directly addresses visible sequelae of body-focused repetitive behaviors that maintain body image distress.

  • Excoriation disorder (F42.4) — skin repair
  • Self-harm scarring with body image distress
  • PTSD with somatic skin burden
  • Trichotillomania — follicular repair after pulling

L-Lysine

Oral

Cortisol modulation · GABA-A/serotonin · Anxiety · Collagen support

L-Lysine is an essential amino acid with established evidence for cortisol modulation and interactions at the GABA-A and serotonin receptor. Particularly relevant in anxiety with HPA axis dysregulation and in excoriation disorder for collagen substrate support.

  • GAD with cortisol-driven anxiety pattern
  • PTSD with HPA axis dysregulation
  • Excoriation disorder — collagen substrate support
  • Low interaction burden at therapeutic doses

Access

Ongoing peptide therapy requires active membership

Peptide management is monitored within scheduled psychiatric follow-up visits. Active membership is required for ongoing prescribing, titration, response tracking, and safety review. Medications are sourced and paid for directly by the patient through Empower Pharmacy or Preston’s Pharmacy.

Core Membership

$325 / month or $3,250 / year

Includes one monthly 30-minute follow-up visit, lab ordering and review, peptide management within scheduled visit time, staff-triaged messaging, and an annual 60-minute Precision Health Review.

Signature Membership

$525 / month or $5,250 / year

Includes one monthly 30-minute follow-up plus one 15-minute follow-up, direct physician messaging, clinician-led monthly check-in, after-hours access, and enhanced monitoring depth for complex cases.

Important: Membership covers the clinical management of peptide therapy. Medication cost is separate and paid directly to the compounding pharmacy.

Questions

What patients want to know

Is peptide therapy at Welmivia the same as biohacking or longevity medicine?
No. Every peptide prescription requires a documented qualifying psychiatric diagnosis and a clinical rationale linking the peptide’s mechanism to that presentation. Longevity or performance optimization without a psychiatric indication is outside Welmivia’s scope.
Can Welmivia address SSRI-induced sexual dysfunction with peptides?
Yes. SSRI- and SNRI-induced sexual dysfunction is a primary indication for PT-141 at Welmivia. Unlike PDE5 inhibitors, PT-141 acts centrally on desire circuitry, making it especially useful when the problem is reduced libido or arousal rather than purely vascular dysfunction.
How does the oxytocin prescription work for social anxiety?
Intranasal oxytocin reduces amygdala reactivity to social threat and can improve approach behavior, trust, and felt social ease. It may be used as-needed before social exposure or on a more regular schedule depending on the psychiatric presentation.
Do I need to travel for this care?
No. Welmivia is a Virginia and Florida telehealth practice. Visits occur by secure video, prescriptions are sent to compounding pharmacies, and lab orders are completed locally through LabCorp or Quest with results reviewed in follow-up.
Do all patients qualify for peptide therapy?
No. Peptides are prescribed only when there is a documented psychiatric indication, an appropriate clinical fit, and a clear rationale for use. Not every patient needs them, and not every peptide is appropriate for every diagnosis.

Ready to explore peptide support thoughtfully?

New patients begin with a Precision Psychiatric Evaluation to review goals, medical and psychiatric context, current treatment, and whether peptide-based support belongs in an integrated plan.

Ready to schedule?

Start with a Precision Psychiatric Evaluation

Interested in integrated GLP-1, hormone, peptide, hair, or sexual wellness support? New patients begin with a comprehensive Precision Psychiatric Evaluation to clarify goals, review history, and determine whether these services fit appropriately within your care plan.

Initial evaluation: $450
Virginia & Florida residents only
Direct-pay · Superbills on request

Ongoing monitored adjunctive therapies, including GLP-1 and peptide-based metabolic management, are addressed within the Welmivia care framework after evaluation when clinically appropriate.

Virginia & Florida Telehealth · Direct-Pay

Start with a free 10-minute fit call

Peptide therapy at Welmivia begins with a $450 Precision Psychiatric Evaluation. This establishes your diagnosis, your Blueprint, and whether any of the agents above are clinically indicated for your presentation.

Schedule Your Fit Call

Welmivia Medical, PLLC  ·  Dr. Sonia Mia Diaz, M.D.  ·  Virginia & Florida Telehealth  ·  Direct-Pay  ·  Superbills Available
This page is for informational purposes only. Peptide therapy requires a clinical evaluation and active membership. Regulatory status of compounded peptides is subject to change.